This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Avanir Pharmaceuticals Announces Multiple Data Presentations Related To Pseudobulbar Affect (PBA) Prevalence And Treatment At Two Conferences In June

Stocks in this article: AVNR

ALISO VIEJO, Calif., May 30, 2014 /PRNewswire/ --  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that data related to the prevalence and treatment of pseudobulbar affect (PBA), a distressing neurological condition characterized by uncontrollable laughing or crying, will be presented at the following conferences in June.

Avanir Pharmaceuticals, Inc.

Joint Congress of European Neurology (EFNS-ENS), May 31 - June 3, 2014, Istanbul

  • Burden of pseudobulbar affect (PBA) symptoms in veterans with traumatic brain injury (TBI)
    • Abstract Number: A-635-0018-01071
    • Poster Session: Neuro-epidemiology; Neurorehabilitation
    • Time: June 1 at 12:30 p.m. EEST
  • Dextromethorphan/Quinidine (DMQ) treatment significantly increased percentage of days free of pseudobulbar affect (PBA) episodes in a phase 3, randomized, placebo-controlled trial
    • Abstract Number: A-635-0005-02074
    • Poster Session: Clinical neurophysiology
    • Time: June 1 at 12:30 p.m. EEST
  • Dextromethorphan/Quinidine for treatment of pseudobulbar affect: analysis of treatment-related adverse events
    • Abstract Number: A-635-0005-02075
    • Poster Session: Clinical neurophysiology
    • Time: June 1 at 12:30 p.m. EEST
  • Time to sustained remission of pseudobulbar affect (PBA) episodes after treatment with dextromethorphan and quinidine
    • Abstract Number: A-635-0005-02618
    • Poster Session: Clinical neurophysiology
    • Time: June 1 at 12:30 p.m. EEST




International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 31 - June, 4, 2014, Montreal
  • Screening for PBA Symptoms Using a Single Question vs. a 7 Question Measure and Assessment of the Association of PBA Symptoms with HRQOL Burden
    • Abstract Number: PND45
    • Session: Research Posters Session I
    • Time: June 2 at 1:15 p.m. EDT

About PBAPBA is a neurologic condition characterized by uncontrollable, disruptive laughing and/or crying outbursts that are often contrary or exaggerated to the patient's inner mood state. As a result, many of those afflicted with PBA show significant impairment on standard measures of health status, and impairments in occupational and social function, often leading to social isolation. PBA occurs secondary to a variety of neurologic conditions such as traumatic brain injury (TBI), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Parkinson's disease, stroke and Alzheimer's disease. When these disorders damage areas of the brain that regulate normal emotional expression, they can lead to uncontrollable, disruptive episodes of crying or laughing. For more information about PBA, please visit  www.pbafacts.com



1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs